Teleflex Inc., US8793691069

The Teleflex Arrow EZ-IO System. A rugged emergency access tool built for seconds

05.07.2026 - 04:25:34 | ad-hoc-news.de

Teleflex Arrow EZ-IO System gives first responders bone-deep vascular access in under 10 seconds in adult and pediatric emergencies. Anyone holding Teleflex stock (NYSE: TFX, ISIN US8793691069) should know this product.

Teleflex Inc., US8793691069
Teleflex Inc., US8793691069

By Julian Reed, ad hoc news Classics & Longsellers Desk. Reviewed July 05, 2026, 2:20 AM ET. Details in the imprint.

Teleflex Arrow EZ-IO System is one of those products you only notice in the worst moments, like when a paramedic kneels on a dim ER floor and the soft whir of the handheld driver cuts through the noise. A nurse pushes the trigger, feels the pop as the needle enters bone, and suddenly a critical patient has access for fluids and drugs. It is brutally practical medical hardware, engineered for seconds, not style.

What the Arrow EZ-IO System does

The Arrow EZ-IO System is an intraosseous vascular access device that lets clinicians deliver medications and fluids directly into the bone marrow when traditional IV lines are too slow or impossible. Teleflex’s official product page describes it as indicated for emergent, urgent and medically necessary intraosseous access in adults and children. The system has been around for years but remains a staple on EMS trucks, helicopters and emergency departments across the US.

At its core, the product is a compact, battery-powered driver paired with single-use needle sets designed for different patient sizes and access sites. A Teleflex clinical insertion guide outlines the standard insertion points, including proximal tibia, distal femur, and humeral head. In practice, many US ER teams favor the proximal humerus for faster central circulation, while prehospital crews often choose the tibia for easier landmarking through pants and gear.

Dig deeper

Teleflex Arrow EZ-IO and TFX earnings

For a closer look at Teleflex’s portfolio and how the Arrow EZ-IO System fits into its vascular access segment, review more articles and the latest company filings.

US use, training and clinical backing

In US hospitals, the Arrow EZ-IO System shows up in crash carts, trauma bays and pediatric resuscitation rooms. Emergency physician Dr. Heather Davis describes it as "the device you reach for when every second to establish access matters" in a Teleflex-sponsored case discussion, noting its use in pulseless electrical activity arrests and severe shock cases. A detailed EMS1 article reports that intraosseous access has become part of standard algorithms in many EMS systems.

From a first-hand perspective, the tactile experience is distinctive: the driver hums, then suddenly the resistance disappears as the needle enters the medullary space. That feedback matters when you are working through sweat and siren noise. Educators like paramedic instructor Jason Seitz emphasize that crews must practice landmarking on training manikins and live volunteers so that the movement becomes almost automatic. A clinical review in the Western Journal of Emergency Medicine notes that intraosseous lines can provide similar pharmacokinetics to traditional IV access for many resuscitation drugs, reinforcing why devices like EZ-IO have managed to stay relevant over more than a decade.

Design, components and practical details

Teleflex sells the Arrow EZ-IO System in several configurations, including a handheld driver and single-use needle kits with color-coded hub sizes. A Bound Tree Medical catalog listing shows street pricing for the driver unit typically in the hundreds of dollars, while needles and extension sets are priced per piece. For US hospital systems and municipal EMS agencies, Teleflex typically negotiates contract prices below list, so retail catalog numbers mainly frame the budget ballpark.

The driver itself has a simple physical interface: one prominent trigger, a rugged grip that works with gloved hands, and an LED that confirms power status. In a training lab, you can feel the weight shift as you angle it toward the humeral head on a plastic manikin, aiming slightly posterior to avoid the bicipital groove. Teleflex’s product literature stresses single-patient use of each needle set, and the company includes detailed instructions and warnings inside the sterile packaging. A system brochure highlights that the device is intended for trained personnel and that insertion sites should be flushed and monitored closely.

Regulatory status and clinical evidence

The Arrow EZ-IO System is FDA-cleared as a Class II device for intraosseous access, with Teleflex referencing multiple 510(k) filings and long-standing use in US clinical practice. An FDA 510(k) summary describes intraosseous blood flow as sufficient for emergency infusion when peripheral veins are inaccessible. Clinical studies collected in the Western Journal of Emergency Medicine and other journals show high success rates for initial insertion, often above 90%, and relatively low complication rates when protocols are followed.

Teleflex also backs the system with training resources through Teleflex Academy and field educators. In a recorded in-service, Teleflex clinical specialist Maria González walks emergency nurses through step-by-step insertion on a simulated trauma patient and underscores post-procedure monitoring, including watching for extravasation and limb swelling. The Teleflex Academy education portal offers videos, case studies and printable guides, which many US hospitals integrate into onboarding for new emergency and critical care staff.

Market role and Teleflex stock context

From a market perspective, the Arrow EZ-IO System sits inside Teleflex’s vascular access product family, alongside central venous catheters and other access solutions. While Teleflex does not break out EZ-IO revenue specifically, its Vascular Access segment contributes a meaningful portion of total sales, and emergency-use disposables like EZ-IO needles support recurring revenue across hospital and EMS budgets. Teleflex’s latest annual report underscores the importance of critical care and vascular access products to its overall portfolio.

Shares of Teleflex (NYSE: TFX) give US investors exposure to this kind of procedural hardware, though no single product, including Arrow EZ-IO, dominates the story on its own. The company’s investor materials emphasize broad-based growth across vascular access, anesthesia and interventional products rather than highlighting one hero device, but for frontline clinicians, Arrow EZ-IO remains a quietly important workhorse in high-acuity care.

Arrow EZ-IO System at a glance

  • Product: Teleflex Arrow EZ-IO System
  • Manufacturer: Teleflex Incorporated
  • Category: Classics & Longsellers emergency vascular access device
  • Launch: Initially introduced in the mid-2000s, with ongoing updates and training resources
  • MSRP / Price: Driver unit typically in the hundreds of USD per piece in US catalogs; single-use needle sets priced per unit, with exact pricing varying by contract
  • Availability: Widely available in US hospitals, EMS agencies and military medical units through Teleflex and distributors
  • Target audience: Trained emergency physicians, anesthesiologists, critical care nurses, paramedics and other advanced life support providers
  • Standout / USP: Rapid, reliable intraosseous access for adult and pediatric patients when conventional IV lines are difficult or impossible, supported by extensive training materials and long-term clinical experience.

Find the Arrow EZ-IO System in action

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.

en | US8793691069 | TELEFLEX INC. | boerse | 69692287 | bgmi